share_log

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $11

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $11

HC Wainwright & Co. 維持對 sensus healthcare 的買入評級,提升目標價至 $11
Benzinga ·  11/18 07:53  · 評級/大行評級

HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $10 to $11.

HC Wainwright & Co. 分析師陳毅維持Sensus Healthcare(納斯達克股票代碼:SRTS)的買入並將目標股價從10美元上調至11美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論